Rovin Capital Merck & Co., Inc. Transaction History
Rovin Capital
- $278 Million
- Q4 2024
A detailed history of Rovin Capital transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rovin Capital holds 2,927 shares of MRK stock, worth $287,665. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,927
Previous 1,769
65.46%
Holding current value
$287,665
Previous $201,000
44.78%
% of portfolio
0.1%
Previous 0.07%
Shares
11 transactions
Others Institutions Holding MRK
# of Institutions
3,815Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.7 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.45 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.81 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $249B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...